|
1
|
American Cancer Society. Cancer Facts and
Figures. 2010
|
|
2
|
Corrado F, Mannini D, Ferri C, Corrado G,
Bertoni F, Bacchini P, Lieber MM and Song JM: The prognostic
significance of DNA ploidy pattern in transitional cell cancer of
the renal pelvis and ureter: continuing follow-up. Eur Urol.
21(Suppl 1): 48–50. 1992.PubMed/NCBI
|
|
3
|
Hall MC, Womack S, Sagalowsky AI, Carmody
T, Erickstad MD and Roehrborn CG: Prognostic factors, recurrence,
and survival in transitional cell carcinoma of the upper urinary
tract: a 30-year experience in 252 patients. Urology. 52:594–601.
1998.PubMed/NCBI
|
|
4
|
Kikuchi E, Horiguchi Y, Nakashima J,
Hatakeyama N, Matsumoto M, Nishiyama T and Murai M: Lymphovascular
invasion independently predicts increased disease specific survival
in patients with transitional cell carcinoma of the upper urinary
tract. J Urol. 174:2120–2123. 2005. View Article : Google Scholar
|
|
5
|
Onitilo AA, Engel JM, Greenlee RT and
Mukesh BN: Breast cancer subtypes based on ER/PR and Her2
expression: comparison of clinicopathologic features and survival.
Clin Med Res. 7:4–13. 2009. View Article : Google Scholar
|
|
6
|
Hutchins G, Southward K, Handley K, Magill
L, Beaumont C, Stahlschmidt J, Richman S, Chambers P, Seymour M,
Kerr D, Gray R and Quirke P: Value of mismatch repair, KRAS, and
BRAF mutations in predicting recurrence and benefits from
chemotherapy in colorectal cancer. J Clin Oncol. 29:1261–1270.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tillett WS and Francis T: Serological
reaction in pneumonia with a non-protein somatic fraction of
pnemoncoccus. J Exp Med. 52:561–571. 1930. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castell JV, Gómez-Lechón MJ, David M,
Fabra R, Trullenque R and Heinrich PC: Acute-phase response of
human hepatocytes; regulation of acute-phase protein synthesis by
interleukin-6. Hepatology. 12:1179–1186. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zimmerman MA, Selzman CH, Cothren C,
Sorensen AC, Raeburn CD and Harken AH: Diagnostic implications of
C.reactive protein. Arch Surg. 138:220–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamura T, Matsumine A, Matsubara T,
Asanuma K, Uchida A and Sudo A: Clinical significance of
pretreatment serum C-reactive protein level in soft tissue sarcoma.
Cancer. 15:1055–1061. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA,
Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, Kim KH, Han JY and Kim HJ:
Clinical significances of preoperative serum interleukin-6 and
C-reactive protein level in operable gastric cancer. BMC Cancer.
9:1552009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pine SR, Mechanic LE, Enewold L,
Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso
NE and Harris CC: Increased levels of circulating interleukin 6,
interleukin 8, C-reactive protein, and risk of lung cancer. J Natl
Cancer Inst. 103:1112–1122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee S, Choe JW, Kim HK and Sung J:
High-sensitivity C-reactive protein and cancer. J Epidemiol.
21:161–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hefler LA, Concin N, Hofstetter G, Marth
C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C,
Tempfer CB and Reinthaller A: Serum C-reactive protein as
independent prognostic variable in patients with ovarian cancer.
Clin Cancer Res. 14:710–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crumley AB, McMillan DC, McKernan M, Going
JJ, Shearer CJ and Stuart RC: An elevated C-reactive protein
concentration, prior to surgery, predicts poor cancer-specific
survival in patients undergoing resection for gastrooesophageal
cancer. Br J Cancer. 94:1568–1571. 2006.
|
|
16
|
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J,
Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga
H, Imaizumi T, Kojiro M and Sata M: Serum C-reactive protein levels
predict survival in hepatocellular carcinoma. Liver Int.
27:1091–1097. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Polterauer S, Grimm C, Tempfer C, Sliutz
G, Speiser P, Reinthaller A and Hefler LA: C-reactive protein is a
prognostic parameter in patients with cervical cancer. Gynecol
Oncol. 107:114–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishizuka M, Nagata H, Takagi K and Kubota
K: C-reactive protein is associated with distant metastasis of T3
colorectal cancer. Anticancer Res. 32:1409–1415. 2012.PubMed/NCBI
|
|
19
|
Lee WS, Baek JH, You DH and Nam MJ:
Prognostic value of circulating cytokines for stage III colon
cancer. J Surg Res. 182:49–54. 2012.PubMed/NCBI
|
|
20
|
Lin MS, Huang JX, Zhu JY and Shen HZ:
Elevation of platelet count in patients with colorectal cancer
predicts tendency to metastases and poor prognosis.
Hepatogastroenterology. 59:1687–1690. 2012.PubMed/NCBI
|
|
21
|
Saito K, Kawakami S, Ohtsuka Y, Fujii Y,
Masuda H, Kumagai J, Kobayashi T, Kageyama Y and Kihara K: The
impact of preoperative serum C-reactive protein on the prognosis of
patients with upper urinary tract urothelial carcinoma treated
surgically. BJU Int. 100:269–273. 2007. View Article : Google Scholar
|
|
22
|
Stein B, Schrader AJ, Wegener G, Seidel C,
Kuczyk MA and Steffens S: Preoperative serum C- reactive protein: a
prognostic marker in patients with upper urinary tract urothelial
carcinoma. BMC Cancer. 13:101–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Helicobacter and Cancer Collaborative
Group. Gastric cancer and Helicobacter pylori: a combined analysis
of 12 case control studies nested within prospective cohorts. Gut.
49:347–353. 2001. View Article : Google Scholar
|
|
25
|
Eaden JA, Abrams KR and Mayberry JF: The
risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut. 48:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jess T, Gamborg M, Matzen P, Munkholm P
and Sørensen TI: Increased risk of intestinal cancer in Crohn’s
disease: a meta-analysis of populationbased cohort studies. Am J
Gastroenterol. 100:2724–2729. 2005.
|
|
27
|
Kushner I, Rzewnicki D and Damols D: What
does minor elevation of C-reactive protein signify? Am J Med.
119:166.e17–e28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heikkilä K, Ebrahim S and Lawlor DA: A
systematic review of the association between circulating
concentrations of C reactive protein and cancer. J Epidemiol
Community Health. 61:824–833. 2007.PubMed/NCBI
|
|
29
|
Nozoe T, Saeki H and Sugimachi K:
Significance of preoperative elevation of serum C-reactive protein
as an indicator of prognosis in esophageal carcinoma. Am J Surg.
182:197–201. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanjay P, de Figueiredo RS, Leaver H,
Ogston S, Kulli C, Polignano FM and Tait IS: Preoperative serum
C-reactive proteinlevels and post-operative lymph node ratio are
important predictors of survival after pancreaticoduodenectomy for
pancreatic ductal adenocarcinoma. JOP. 13:199–204. 2012.
|
|
31
|
Slaviero KA, Clarke SJ and Rivory LP:
Inflammatory response: an unrecognised source of variability in the
pharmacokinetics and pharmacodynamics of cancer chemotherapy.
Lancet Oncol. 4:224–232. 2003.PubMed/NCBI
|
|
32
|
Erlinger TP, Platz EA, Rifai N and
Helzlsouer KJ: C-reactive protein and the risk of incident
colorectal cancer. JAMA. 291:585–590. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gunter MJ, Stolzenberg-Solomon R, Cross
AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR,
Albanes D and Sinha R: A prospective study of serum C-reactive
protein and colorectal cancer risk in men. Cancer Res.
66:2483–2487. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Il’yasova D, Colbert LH, Harris TB, Newman
AB, Bauer DC, Satterfield S and Kritchevsky SB: Circulating levels
of inflammatory markers and cancer risk in the health aging and
body composition cohort. Cancer Epidemiol Biomarkers Prev.
14:2413–2418. 2005.PubMed/NCBI
|
|
35
|
Ito Y, Suzuki K, Tamakoshi K, Wakai K,
Kojima M, Ozasa K, Watanabe Y, Kawado M, Hashimoto S, Suzuki S,
Tokudome S, Toyoshima H, Hayakawa N, Kato K, Watanabe M, Ohta Y,
Maruta M and Tamakoshi A; JACC Study Group. Colorectal cancer and
serum C-reactive protein levels: a case control study nested in the
JACC Study. J Epidemiol. 15(Suppl 2): S185–S189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Otani T, Iwasaki M, Sasazuki S, Inoue M
and Tsugane S: Plasma C-reactive protein and risk of colorectal
cancer in a nested case-control study: Japan Public Health
Center-based prospective study. Cancer Epidemiol Biomarkers Prev.
15:690–695. 2006. View Article : Google Scholar
|
|
37
|
Siemes C, Visser LE, Coebergh JW, et al:
C-reactive protein levels, variation in the C-reactive protein
gene, and cancer risk: the Rotterdam Study. J Clin Oncol.
24:5216–5222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Trichopoulos D, Psaltopoulou T, Orfanos P,
Trichopoulou A and Boffetta P: Plasma C-reactive protein and risk
of cancer: a prospective study from Greece. Cancer Epidemiol
Biomarkers Prev. 15:381–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang SM, Buring JE, Lee IM, Cook NR and
Ridker PM: C-reactive protein levels are not associated with
increased risk for colorectal cancer in women. Ann Intern Med.
142:425–432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ognjanovic S, Yamamoto J, Saltzman B,
Franke A, Ognjanovic M, Yokochi L, Vogt T, Decker R and Le Marchand
L: Serum CRP and IL-6, genetic variants and risk of colorectal
adenoma in a multiethnic population. Cancer Causes Control.
21:1131–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tsilidis KK, Branchini C, Guallar E,
Helzlsouer KJ, Erlinger TP and Platz EA: C-reactive protein and
colorectal cancer risk: a systematic review of prospective studies.
Int J Cancer. 123:1133–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo YZ, Pan L, Du CJ, Ren DQ and Xie XM:
Association between C-reactive protein and risk of cancer: a
meta-analysis of prospective cohort studies. Asian Pacific J Cancer
Prev. 14:243–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gunter MJ, Stolzenberg-Solomon R, Cross
AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR,
Albanes D and Sinha R: A prospective study of serum C-reactive
protein and colorectal cancer risk in men. Cancer Res.
66:2483–2487. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bollschweiler E, Metzger R, Drebber U,
Baldus S, Vallböhmer D, Kocher M and Hölscher AH: Histological type
of esophageal cancer might affect response to neo-adjuvant
radiochemotherapy and subsequent prognosis. Ann Oncol. 20:231–238.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
D’Angelo E, Espinosa I, Ali R, Gilks CB,
Rijn M, Lee CH and Prat J: Uterine leiomyosarcomas: tumor size,
mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups
with different prognosis. Gynecol Oncol. 121:328–333.
2011.PubMed/NCBI
|
|
46
|
Ma J, Liu L, Tang L, Zong J, Lin A, Lu T,
Cui N, Cui C and Li L: Retropharyngeal lymph node metastasis in
nasopharyngeal carcinoma: prognostic value and staging categories.
Clin Cancer Res. 13:1445–1452. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zacharakis M, Xynos ID, Lazaris A, Smaro
T, Kosmas C, Dokou A, Felekouras E, Efstathios A, Polyzos A,
Sarantonis J, Syrios J, Zografos G, Papalambros A and Tsavaris N:
Predictors of survival in stage IV metastatic colorectal cancer.
Anticancer Res. 30:653–660. 2010.PubMed/NCBI
|
|
48
|
McMillan DC, Canna K and McArdle CS:
Systemic inflammatory response predicts survival following curative
resection of colorectal cancer. Br J Surg. 90:215–219. 2003.
View Article : Google Scholar
|
|
49
|
Siemes C, Visser LE, Coebergh JW, Splinter
TAW, Witteman JCM, Uitterlinden AG, Hofman A, Pols HAP and Stricker
BH: C-reactive protein levels, variation in the C-reactive protein
gene, and cancer risk: the Rotterdam Study. J Clin Oncol.
24:5216–5222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ramsey S, Lamb GWA, Aitchison M and
McMillan DC: The longitudinal relationship between circulating
concentrations of C-reactive protein, interleukin-6 and
interleukin-10 in patients undergoing resection for renal cancer.
Br J Cancer. 95:1076–1080. 2006. View Article : Google Scholar
|
|
51
|
Nozoe T, Korenaga D, Futatsugi M, Saeki H,
Maehara Y and Sugimachi K: Immunohistochemical expression of
C-reactive protein in squamous cell carcinoma of the
esophagus-significance as a tumor marker. Cancer Lett. 192:89–95.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rutkowski P, Kaminska J, Kowalska M, Ruka
W and Steffen J: Cytokine serum levels in soft tissue sarcoma
patients: correlations with clinico-pathological features and
prognosis. Int J Cancer. 100:463–471. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wigmore SJ, Fearon KC, Sangster K, Maingay
JP, Garden OJ and Ross JA: Cytokine regulation of constitutive
production of interleukin-8 and -6 by human pancreatic cancer cell
lines and serum cytokine concentrations in patients with pancreatic
cancer. Int J Oncol. 21:881–886. 2002.
|
